<?xml version="1.0" encoding="UTF-8"?>
<results title="drugs">
 <result pre="analysis. Opioid substitution treatment (OST) programs included substitution therapies with" exact="buprenorphine" post="or methadone in a structured program under the supervision"/>
 <result pre="substitution treatment (OST) programs included substitution therapies with buprenorphine or" exact="methadone" post="in a structured program under the supervision of a"/>
 <result pre="use. Four patients (2.3%) had HBsAg detectable and were receiving" exact="tenofovir" post="fumarate 245 mg daily, while 8 (4.6%) patients with"/>
 <result pre="Anemia (hemoglobin &amp;lt;10 g/dL) was reported in 2 patients receiving" exact="ribavirin" post="and resolved after dose reduction in both cases. One"/>
 <result pre="patients needed to discontinue treatment and their anemia improved with" exact="ribavirin" post="dose reduction. In addition, none of the treated PWID"/>
 <result pre="who inject drugsSubst Use Misuse2016511218122327219274 10BaruaSGreenwaldRGrebelyJDoreGJSwanTTaylorLERestrictions for Medicaid reimbursement of" exact="sofosbuvir" post="for the treatment of hepatitis C virus infection in"/>
 <result pre="Med201616562563427537841 14GrebelyJMaussSBrownAet al.Efficacy and safety of ledipasvir/sofosbuvir with and without" exact="ribavirin" post="in patients with chronic HCV genotype 1 infection receiving"/>
 <result pre="al.Real-world experience with the all-oral, interferon-free regimen of ombitasvir/paritaprevir/ritonavir and" exact="dasabuvir" post="for the treatment of chronic hepatitis C virus infection"/>
</results>
